2018 annual financial data
Galectin Therapeutics 2018 Operating margin
Galectin Therapeutics 2018 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -13,602,000 USD and net income was -13,900,000 USD.
Operating cash flow was -10,179,000 USD.
Get free Galectin Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,602,000 USD
- Net income
- -13,900,000 USD
- Operating cash flow
- -10,179,000 USD